Abstract #4313
Mean Diffusivity as a non-invasive biomarker of the amount of amyloid plaques in Alzheimers disease: a preliminary evaluation in a mouse model.
Matteo Figini 1 , Alessandro Scotti 1 , Ileana Zucca 1 , Emanuela Maderna 2 , Margherita Ruggerone 2 , Marcella Catania 2 , Giuseppe Di Fede 2 , Fabio Moda 2 , Fabrizio Tagliavini 2 , and Maria Grazia Bruzzone 3
1
Scientific Direction, Fondazione IRCCS
Istituto Neurologico "Carlo Besta", Milan, Milan, Italy,
2
Neuropathology
Unit, Fondazione IRCCS Istituto Neurologico "Carlo
Besta", Milan, Italy,
3
Neuroradiology
Unit, Fondazione IRCCS Istituto Neurologico "Carlo
Besta", Milan, Italy
In this work, the potential of diffusion MRI (dMRI)
parameters in the characterization of neuropathological
features of Alzheimers diseases was investigated in a
mouse model. Transgenic mice treated with different
doses of a synthetic peptide were submitted to 7T dMRI
at different time points. A reduction of mean
diffusivity was associated with the deposition of
amyloid plaques highlighted by immunohistochemistry. If
this preliminary result will be confirmed in further
works, mean diffusivity may be an in vivo biomarker of
the amount of amyloid plaques, with applications in the
diagnosis and monitoring of therapy effects on
Alzheimers patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
